Seattle, WA, United States of America

Chris Saxby

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Seattle Children's Hospital, University of Washington. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chris Saxby: Innovator in Aptamer Technology

Introduction

Chris Saxby is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly through his innovative work on aptamers. His research focuses on the binding of monocytes and macrophages, which are crucial components of the immune system.

Latest Patents

Chris Saxby holds a patent titled "Monocyte and macrophage binding aptamers and their application." This patent describes compositions comprising aptamers that specifically bind to monocytes and/or macrophages. The methods outlined in the patent can be utilized for isolating and enriching these cell types or depleting populations of monocytes and macrophages. Furthermore, the patent discusses the therapeutic applications of these aptamers and the cell populations generated from them for drug delivery.

Career Highlights

Throughout his career, Chris has worked with prestigious institutions, including the University of Washington and Seattle Children's Hospital. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Some of Chris Saxby's notable coworkers include Suzie H Pun and Meilyn Sylvestre. Their collaborative efforts have contributed to the success of his research and the development of innovative solutions in biotechnology.

Conclusion

Chris Saxby is a pioneering inventor whose work on aptamers has the potential to revolutionize therapies and drug delivery systems. His contributions to the field of biotechnology are significant and continue to impact medical research and applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…